Related Experiment Video
Updated: Aug 6, 2026

03:47
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Spinal tuberculosis: a longitudinal study with clinical, laboratory, and imaging outcomes
Laurence Le Page1, Antoine Feydy, Ludovic Rillardon
1APHP, Service de médecine interne, Hôpital Beaujon, 92110 Clichy, France.
Seminars in Arthritis and Rheumatism
|August 4, 2006
Summary
Imaging abnormalities from spinal tuberculosis (ST) can persist even after successful treatment. Follow-up MRI scans may not be necessary if clinical and laboratory markers show improvement in ST patients.
Area of Science:
- Radiology
- Infectious Diseases
- Orthopedics
Background:
- Spinal tuberculosis (ST) requires long-term monitoring.
- Understanding the evolution of imaging findings during and after treatment is crucial.
Purpose of the Study:
- To track imaging changes in spinal tuberculosis (ST) over time.
- To correlate these imaging changes with clinical and laboratory data.
- To assess the necessity of follow-up MRI in treated ST patients.
Main Methods:
- Prospective enrollment of 19 patients with proven ST treated for 1 year.
- Collection of clinical and laboratory data at baseline and quarterly.
- Serial MRI and CT scans performed at baseline, during treatment, and post-treatment.
Main Results:
- Initial MRI/CT showed high prevalence of paravertebral and epidural abscesses, with significant spinal cord compression in many.
- All 15 patients with full follow-up were cured, with clinical improvement noted within 9 months.
- While clinical markers normalized by 3 months, imaging abnormalities like paravertebral abscesses persisted in some patients up to 12 months post-treatment.
Conclusions:
- Significant imaging abnormalities can remain visible on MRI after successful ST treatment.
- Routine follow-up MRI may not be indicated for ST patients demonstrating clinical and laboratory recovery.
Related Concept Videos
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...